Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial

Cited by (261)

Items 101–200 of 261

1. Gene therapy for lysosomal storage diseases: Current clinical trial prospects
   Jun Kido, Keishin Sugawara, Kimitoshi Nakamura · 2023 · Frontiers in Genetics
2. The ice age – A review on formulation of Adeno-associated virus therapeutics
   Philip Grossen, Irini Skaripa-Koukelli, Joost van Haasteren, Alexandra H.E. Machado, Christoph Dürr · 2023 · European Journal of Pharmaceutics and Biopharmaceutics
3. A Review of Gene Therapy in Canine and Feline Models of Lysosomal Storage Disorders
   Allison M. Bradbury, Brittney L. Gurda, Margret L. Casal, Katherine Parker Ponder, Charles H. Vite, Mark E. Haskins · 2015 · Human Gene Therapy Clinical Development
4. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses
   Valeria De Pasquale, Patrizia Sarogni, Valéria Pistorio, Giuliana Cerulo, Simona Paladino, Luigi Michele Pavone · 2018 · Molecular Therapy — Methods & Clinical Development
5. Gene-Based Approaches to Inherited Neurometabolic Diseases
   Valentina Poletti, Alessandra Biffi · 2019 · Human Gene Therapy
6. Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model
   Keisuke Kitakaze, Yasumichi Mizutani, Eiji Sugiyama, Chikako Tasaki, Daisuke Tsuji, Nobuo Maita, Takatsugu Hirokawa, Daisuke Asanuma, Mako Kamiya, Kohei Sato et al. · 2016 · Journal of Clinical Investigation
7. Therapeutic Strategies For Tay-Sachs Disease
   Jaqueline A. Picache, Wei Zheng, Catherine Z. Chen · 2022 · Frontiers in Pharmacology
8. In Vivo Gene Therapy for Mucopolysaccharidosis Type III (Sanfilippo Syndrome): A New Treatment Horizon
   Sara Marcó, Virginia Haurigot, Fátima Bosch · 2019 · Human Gene Therapy
9. AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains
   Michaël Hocquemiller, Kim M. Hemsley, Meghan L. Douglass, Sarah J. Tamang, Daniel Neumann, Barbara M. King, Helen Beard, Paul J. Trim, Leanne K. Winner, Adeline A. Lau et al. · 2019 · Molecular Therapy — Methods & Clinical Development
10. Gene therapy for lysosomal storage diseases and peroxisomal diseases
    Ohashi, Toya · 2019 · Journal of Human Genetics
11. Gene therapy in pediatrics – Clinical studies and approved drugs (as of 2023)
    Tahereh Mohammadian Gol, Fatemeh Zahedipour, Paul Trosien, Guillermo Ureña-Bailén, Miso Kim, Justin S. Antony, Markus Mezger · 2024 · Life Sciences
12. Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep
    Marcus G. Davey, John Samuel Riley, Abigail Andrews, Alec Tyminski, Maria P. Limberis, Jennifer E. Pogoriler, Emily Anne Partridge, Aliza M. Olive, Holly L. Hedrick, Alan W. Flake et al. · 2017 · PLoS ONE
13. Gene Therapy for Pompe Disease: The Time is now
    Pasqualina Colella, Federico Mingozzi · 2019 · Human Gene Therapy
14. Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice
    Helen Beard, Amanda J. Luck, Sofia Hassiotis, Barbara M. King, Paul J. Trim, Marten F. Snel, John J. Hopwood, Kim M. Hemsley · 2015 · Molecular Genetics and Metabolism
15. A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB
    Aaron S. Meadows, F. Jason Duncan, Marybeth Camboni, Kathryn Waligura, Chrystal L. Montgomery, Kimberly Zaraspe, Bartholomew J. Naughton, William G. Bremer, Christopher J. Shilling, Christopher M. Walker et al. · 2015 · Human Gene Therapy Clinical Development
16. An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA
    Anna L. Gray, Claire O’Leary, Aiyin Liao, Leticia Agúndez, Amir Saam Youshani, Hélène F.E. Gleitz, Helen Parker, Jessica Taylor, Olivier Danos, Michaël Hocquemiller et al. · 2019 · Human Gene Therapy
17. Innovative Treatments for Lysosomal Diseases
    Timothy Martin Cox · 2015 · Best Practice & Research Clinical Endocrinology & Metabolism
18. A systematic review of adeno-associated virus gene therapies in neurology: the need for consistent safety monitoring of a promising treatment
    Rebecca H. Horton, Dimah N. Saade, Theodora Markati, Eli Harriss, Carsten G. Bönnemann, Francesco Muntoni A, Laurent Servais · 2022 · Journal of Neurology Neurosurgery & Psychiatry
19. Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature
    Darren M. Janzen, Kathleen A. Delaney, Elsa Shapiro · 2017 · Molecular Genetics and Metabolism
20. Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart
    Edith Renaud-Gabardos, Florence Tatin, Fransky Hantelys, Benoît Lebas, Denis Calise, Oksana Kunduzova, Bernard Masri, Françoise Pujol, Pierre Sicard, Philippe Valet et al. · 2017 · Molecular Therapy
21. Genetic Engineering and Manufacturing of Hematopoietic Stem Cells
    Xiuyan Wang, Isabelle Rivière · 2017 · Molecular Therapy — Methods & Clinical Development
22. In Vivo Potency Assay for Adeno-Associated Virus–Based Gene Therapy Vectors Using AAVrh.10 as an Example
    Bishnu P. De, Alvin Chen, Christiana O. Salami, Benjamin G. Van de Graaf, Jonathan B. Rosenberg, Odelya E. Pagovich, Dolan Sondhi, Ronald G. Crystal, Stephen M. Kaminsky · 2018 · Human Gene Therapy Methods
23. Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery
    Chantelle McIntyre, Ainslie L.K. Derrick‐Roberts, Sharon Byers, Donald S. Anson · 2014 · The Journal of Gene Medicine
24. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier
    Bethan J. Critchley, Hubert Bobby Gaspar, Sara Benedetti · 2022 · Molecular Therapy
25. Gene therapies for mucopolysaccharidoses
    Alessandro Rossi, Nicola Brunetti‐Pierri · 2023 · Journal of Inherited Metabolic Disease
26. Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho−/− mouse
    Arpad Palfi, Naomi Chadderton, Mary O’Reilly, Kerstin Nagel‐Wolfrum, Uwe Wolfrum B, Jean Bennett, Peter Humphries, Paul F. Kenna, Sophia Millington‐Ward, Jane Farrar · 2015 · Molecular Therapy — Methods & Clinical Development
27. Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome)
    Weijing Kong, Yanqing Yao, Jing Zhang, Cheng Lu, Yingxue Ding, Yan Meng · 2020 · European Journal of Pharmacology
28. Treatment for Lysosomal Storage Disorders
    Jayesh J. Sheth, Aadhira Nair · 2020 · Current Pharmaceutical Design
29. Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges
    Amina Abulimiti, Michael Siu‐Lun Lai, Raymond Chuen‐Chung Chang · 2021 · Mechanisms of Ageing and Development
30. Preclinical Toxicity Evaluation of AAV for Pain: Evidence from Human AAV Studies and from the Pharmacology of Analgesic Drugs
    Pleticha, Josef, Heilmann, Lukas F, Evans, Christopher H, Asokan, Aravind, Samulski, Richard Jude, Beutler, Andreas S · 2014 · Molecular Pain
31. Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders
    Livia Zhou, Yafeng Wang, Yiran Xu, Yaodong Zhang, Changlian Zhu · 2024 · Molecular Therapy — Methods & Clinical Development
32. N -Substituted l -Iminosugars for the Treatment of Sanfilippo Type B Syndrome
    Valeria De Pasquale, Anna Esposito, Gianluca Scerra, Melania Scarcella, Mariangela Ciampa, Antonietta Luongo, Daniele D’Alonzo, Annalisa Guaragna, Massimo D’Agostino, Luigi Michele Pavone · 2023 · Journal of Medicinal Chemistry
33. Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
    Shunji Tomatsu, Isabella Azario, Kazuki Sawamoto, Alice Pievani, Andrea Biondi, Marta Serafini · 2015 · Journal of Inherited Metabolic Disease
34. Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
    Suzan J. G. Knottnerus, Stephanie C. M. Nijmeijer, Lodewijk IJlst, Heleen te Brinke, Naomi van Vlies, Frits A. Wijburg · 2017 · Annals of Neurology
35. Viral gene therapy for paediatric neurological diseases: progress to clinical reality
    R. Privolizzi, W. Chu, Maha Tijani, J. Ng · 2021 · Developmental Medicine & Child Neurology
36. Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
    Karolina Pierzynowska, Lidia Gaffke, Zuzanna Cyske, Grzegorz Węgrzyn, Brigitta Buttari, Elisabetta Profumo, Luciano Saso · 2021 · Molecules
37. High and prolonged sulfamidase secretion by the liver of MPS-IIIA mice following hydrodynamic tail vein delivery of antibiotic-free pFAR4 plasmid vector
    Mickaël Quiviger, Audrey Arfı, D Mansard, L Delacotte, Marie Pastor, Daniel Scherman, Corinne Marie · 2014 · Gene Therapy
38. Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy
    Ryuichi Mashima, Mahito Nakanishi · 2022 · International Journal of Molecular Sciences
39. Gene Therapy for Neurologic Disease: A Neurosurgical Review
    Frederick L. Hitti, Pedro Gonzalez‐Alegre, Timothy H. Lucas · 2018 · World Neurosurgery
40. Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy
    Saori Miwa, Ayako M. Watabe, Yohta Shimada, Takashi Higuchi, Hiroshi Kobayashi, Takahiro Fukuda, Fusao Kato, Hiroyuki Ida, Toya Ohashi · 2020 · Molecular Genetics and Metabolism
41. Targeting Root Cause by Systemic scAAV9-hIDS Gene Delivery: Functional Correction and Reversal of Severe MPS II in Mice
    Haiyan Fu, Kimberly Zaraspe, Naoko Murakami, Aaron S. Meadows, Ricardo J. Pineda, Douglas M. McCarty, Joseph Muenzer · 2018 · Molecular Therapy — Methods & Clinical Development
42. The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury
    Yutaka Hoshino, Kenji Nishide, Narihito Nagoshi, Shinsuke Shibata, Nobuko Moritoki, Kota Kojima, Osahiko Tsuji, Morio Matsumoto, Jun Kohyama, Masaya Nakamura et al. · 2019 · Scientific Reports
43. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group
    Anja Köhn, Lorenz Grigull, Marcel du Moulin, Sarah Kabisch, Luise Sophie Ammer, Cornelia Rudolph, Nicole Muschol · 2020 · Molecular Genetics and Metabolism Reports
44. Mucopolysaccharidosis III: Molecular basis and treatment
    Lıdvana Spahıu, Emir Behluli, Borut Peterlin, Hilada Nefić, Rifat Hadžiselimović, Thomas Liehr, Gazmend Temaj · 2021 · Pediatric Endocrinology Diabetes and Metabolism
45. Complete Correction of Brain and Spinal Cord Pathology in Metachromatic Leukodystrophy Mice
    Emilie Audouard, Valentin Oger, Béatrix Meha, Nathalie Cartier, Caroline Sevin, Françoise Piguet · 2021 · Frontiers in Molecular Neuroscience
46. Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
    Claire Horgan, Simon Allan Jones, Brian Bigger, Robert Francis Wynn · 2022 · International Journal of Molecular Sciences
47. Incidence, timing, and clinical significance of adverse immune events after gene replacement therapy: A systematic review and meta-analysis
    Niccolò Maurizi, Enrico Ammirati, Elizabeth Silver, Kimberly Hong, Quan M. Bui, Alessia Argirò, Iacopo Olivotto, Eric D. Adler · 2026 · Molecular Therapy
48. Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis
    Karolina M. Stępień, Andrew M. Bentley, Cliff Chen, M. Wahab Dhemech, Edward C. A. Gee, Peter K Orton, Catherine Pringle, Jonathan Niranjan Rajan, Ankur Saxena, Govind Tol et al. · 2022 · Frontiers in Cardiovascular Medicine
49. The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
    Alexis David, Thibault Chazeirat, Ahlame Saidi, Gilles Lalmanach, Fabien Lecaille · 2023 · Biomedicines
50. Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
    Yonghong Chen, Zheng Shujuan, Luis Tecedor, Beverly L. Davidson · 2018 · Molecular Therapy
51. Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
    Nicolina Cristina Sorrentino, Vincenzo Cacace, Maria De Risi, Veronica Maffia, Sandra Strollo, Novella Tedesco, Edoardo Nusco, Noemi Romagnoli, Domenico Ventrella, Yan Huang et al. · 2019 · Molecular Therapy — Methods & Clinical Development
52. Structural Study of Aavrh.10 Receptor and Antibody Interactions
    Mario Mietzsch, Jennifer C. Yu, Jane Hsi, Paul R. Chipman, Felix Broecker, Zhang Fuming, Robert J. Linhardt, Peter H. Seeberger, Regine Heilbronn, Robert McKenna et al. · 2021 · Journal of Virology
53. Phase I and II clinical trials for the mucopolysaccharidoses
    Fabiano de Oliveira Poswar, Guilherme Baldo, Roberto Giugliani · 2017 · Expert Opinion on Investigational Drugs
54. Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art
    Giulia Consiglieri, Maria Ester Bernardo, Nicola Brunetti‐Pierri, Alessandro Aiuti · 2022 · Hematology/Oncology Clinics of North America
55. Gene Therapy: A New Approach in Modern Medicine
    Azam Yazdani, Zahra Alirezaie, Mohammad Javad Motamedi, Jafar Amani · 2018 · International Journal of Medical Reviews
56. Convection-Enhanced Delivery in Children: Techniques and Applications
    Kristian Aquilina, Anupam Chakrapani, Lucinda Carr, Manju A. Kurian, Darren R. Hargrave · 2022 · Advances and technical standards in neurosurgery
57. Perspective on innovative therapies for globoid cell leukodystrophy
    Alessandra Ricca, Angela Gritti · 2016 · Journal of Neuroscience Research
58. AAV delivery of GBA1 suppresses α-synuclein accumulation in Parkinson’s disease models and restores functions in Gaucher’s disease models
    Takuro Okai, Sho Sato, Mugdha Deshpande, Shin-ichi Matsumoto, Miyu Nakayama, Syunsuke Yamamoto, Bettina Strack-Logue, Takeshi Hioki, Maiko Tanaka, Gabriele Proetzel · 2025 · PLoS ONE
59. Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model
    Jie Gong, Yunyun Liu, Tsai‐Hua Chung, Liu Xu, Troy C. Lund, Lung‐Ji Chang · 2022 · Gene Therapy
60. Gene Therapy for Lysosomal Storage Disorders
    Esteban Alberto Gonzalez, Guilherme Baldo · 2017 · Journal of Inborn Errors of Metabolism and Screening
61. Neuronal and Astrocytic Differentiation from Sanfilippo C Syndrome iPSCs for Disease Modeling and Drug Development
    Noelia Benetó, Mónica Cozar, Laura Castilla‐Vallmanya, Oskar G. Zetterdahl, Mãdãlina Sãcultanu, Eulàlia Segur‐Bailach, María García-Morant, Antònia Ribes, Henrik Ahlenius, Daniel Grinberg et al. · 2020 · Journal of Clinical Medicine
62. Current and Emerging Therapies for Mucopolysaccharidoses
    Florian B. Lagler · 2019 · Handbook of experimental pharmacology
63. Mucopolysaccharidosis type III-A
    2004 · Springer eBooks
64. Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector
    Tierra A. Bobo, Preston N. Samowitz, Michael I. Robinson, Haiyan Fu · 2020 · Molecular Therapy — Methods & Clinical Development
65. Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood‐onset dementia
    Leanne K. Winner, Mary‐Louise Rogers, Marten F. Snel, Kim M. Hemsley · 2023 · Journal of Neurochemistry
66. Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
    Claire O’Leary, Gabriella M. A. Forte, Nadia L. Mitchell, Amir Saam Youshani, A. Stephens Dyer, Martin P. Wellby, Katharina N. Russell, Samantha J. Murray, Nelly Jolinon, Simon Allan Jones et al. · 2023 · Journal of Translational Medicine
67. Current and Future Treatments for Lysosomal Storage Disorders
    David P. W. Rastall, Andrea Amalfitano · 2017 · Current Treatment Options in Neurology
68. Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions
    Julie Uchitel, Boris Kantor, Edward C. Smith, Mohamad A. Mikati · 2020 · Pediatric Neurology
69. Neuraminidase‐mediated desialylation augments AAV9‐mediated gene expression in skeletal muscle
    Hongling Zhu, Tao Wang, Robert John Lye, Brent A. French, Brian Herb Annex · 2018 · The Journal of Gene Medicine
70. Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA
    Marianna Bugiani, Truus E. M. Abbink, Arthur W. D. Edridge, Lia van der Hoek, Anne E.J. Hillen, Niek Peter van Til, Gino V. Hu‐A‐Ng, Marjolein Breur, Karen Aiach, Philippe Drevot et al. · 2023 · Annals of Clinical and Translational Neurology
71. A Multiparametric Computational Algorithm for Comprehensive Assessment of Genetic Mutations in Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome)
    Krastyu G. Ugrinov, Stefan D. Freed, Clayton L. Thomas, Shaun W. Lee · 2015 · PLoS ONE
72. Intrathecal AAVrh10 corrects biochemical and histological hallmarks of mucopolysaccharidosis VII mice and improves behavior and survival
    Gemma Pagès, Lydia Giménez‐Llort, Belén García-Lareu, Lorena Ariza, Marc Navarro, Caty Casas, Miguel Chillón, Assumpció Bosch · 2019 · Human Molecular Genetics
73. Evolving therapies in neuronopathic LSDs: opportunities and challenges
    Deepa Soundara Rajan, Maria Luisa Escolar · 2022 · Metabolic Brain Disease
74. Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice
    John Robert Counsell, Rajvinder Karda, Juan F. Antinao Diaz, Louise Carey, Tatiana Wiktorowicz, Suzanne M. K. Buckley, Shima Ameri, Joanne Ng, Julien Baruteau, Filipa Almeida et al. · 2018 · Molecular Therapy — Nucleic Acids
75. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration
    Lau, Adeline A., Hemsley, Kim M. · 2017 · Journal of Molecular Medicine
76. The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives
    Noemi Veraldi, Nawel Zouggari, Ariane I. de Agostini · 2020 · Molecules
77. Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T Cells
    Bishnu P. De, Sara Cram, Hyunmi Lee, Jonathan B. Rosenberg, Dolan Sondhi, Ronald G. Crystal, Stephen M. Kaminsky · 2023 · Human Gene Therapy
78. Biomarkers for gene therapy clinical trials of lysosomal storage disorders
    Alessandro Rossi, Sabrina Malvagia, Giancarlo la Marca, Giancarlo Parenti, Nicola Brunetti‐Pierri · 2024 · Molecular Therapy
79. Adeno-Associated Viral Vectors in the Treatment of Epilepsy
    Aysilu I. Mullagulova, Тимечко Елена Евгеньевна, Valeriya V. Solovyeva, Alexey M. Yakimov, Ahmad Ibrahim, Д. В. Дмитренко, Albert Akramovich Sufianov, Г. З. Суфианова, Albert Anatolyevich Rizvanov · 2024 · International Journal of Molecular Sciences
80. E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer's Disease Mouse Model 5xFAD
    Noelia López‐Sánchez, Alberto Garrido‐García, Morgan Ramón‐Landreau, Vanesa Cano‐Daganzo, José María Frade · 2021 · Neurotherapeutics
81. Nature Biotechnology's academic spinouts of 2014
    Aaron J. Bouchie, Laura DeFrancesco · 2015 · Nature Biotechnology
82. Incentives for Starting Small Companies Focused on Rare and Neglected Diseases
    Sean Ekins, Jill Wood · 2015 · Pharmaceutical Research
83. Evidence Synthesis of Gene Therapy and Gene Editing from Different Disorders—Implications for Individuals with Rett Syndrome: A Systematic Review
    Jatinder Singh, Ella Goodman-Vincent, Paramala Santosh · 2023 · International Journal of Molecular Sciences
84. Is the eye a window to the brain in Sanfilippo syndrome?
    Helen Beard, Glyn Chidlow, Daniel Neumann, Nazzmer Nazri, Meghan L. Douglass, Paul J. Trim, Marten F. Snel, Robert James Casson, Kim M. Hemsley · 2020 · Acta Neuropathologica Communications
85. Variables influencing fluorimetric N-sulfoglucosamine sulfohydrolase (SGSH) activity measurement in brain homogenates
    Lauren S. Whyte, John J. Hopwood, Kim M. Hemsley, Adeline A. Lau · 2015 · Molecular Genetics and Metabolism Reports
86. Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay–Sachs Disease
    María González-Sánchez, Marı́a Jesús Ramı́rez-Expósito, José Manuel Martı́nez-Martos · 2025 · Neurology International
87. Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases
    Rrita Daci, Heather L. Gray‐Edwards, Mohammed Salman Shazeeb, Zeynep Vardar, Behroze Adi Vachha, Oguz I. Cataltepe, Terence R. Flotte · 2024 · Human Gene Therapy
88. Life‐Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy
    Aime K. Johnson, Victoria J. McCurdy, Heather L. Gray‐Edwards, Anne S. Maguire, J. Nicholas Cochran, Amanda L. Gross, Haleigh E. Skinner, Ashley N. Randle, Jamie L. Shirley, Brandon L. Brunson et al. · 2023 · Annals of Neurology
89. Mucopolysaccharidosis type III: current clinical trials, challenges and recommendations
    Stephanie C. M. Nijmeijer, Frits A. Wijburg · 2017 · Expert Opinion on Orphan Drugs
90. Viral Vectors for Gene Therapy
    Clévio Nóbrega, Liliana S. Mendonça, Carlos A. Matos · 2020 · Springer eBooks
91. Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment
    Min Hak Lee, Sukyeong Kang, Ki Hwan Um, Seok Won Lee, Hyorin Hwang, Kyunghwa Baek, Jin Woo Choi · 2024 · Journal of Translational Medicine
92. Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA
    Giaccio Marianna, Antonio Monaco, Galiano Laura, Andrea Parente, Luigi Borzacchiello, Rubino Riccardo, Klärner Frank-Gerrit, Killa Dennis, Claudia Perna, Pasquale Piccolo et al. · 2024 · Molecular Therapy
93. Clinical Development of Cell Therapies to Halt Lysosomal Storage Diseases: Results and Lessons Learned
    Valeria Graceffa · 2021 · Current Gene Therapy
94. Lysosomal Storage Disorders
    Angela Sun, Irene J. Chang, Christina T. Lam, Gerard T. Berry · 2021 · Elsevier eBooks
95. The Mucopolysaccharidoses
    Giancarlo Parenti, Roberto Giugliani · 2022 · Springer eBooks
96. Phase I clinical trial of intracerebral injection of lentiviral-ABCD1 for the treatment of cerebral adrenoleukodystrophy
    Qiuhong Wang, Jing Wang, Zhipei Ling, Zhiqiang Cui, Jie Gong, Rui Zhang, Shijun Li, Yangyang Wang, Rui Yang, Dehui Huang et al. · 2024 · 中国科学通报：英文版
97. Direct Convective Delivery for Nervous System Gene Therapy
    James Bradley Elder, Russell R. Lonser · 2024 · Neurosurgery Clinics of North America
98. Gene regulation and genetics in neurochemistry, past to future
    Steven W. Barger · 2016 · Journal of Neurochemistry
99. Genetic therapies for neurological diseases
    Ahad A. Rahim, Manju A. Kurian, Haiyan Zhou, Ross Ferguson, Sarah J. Tabrizi, Gabriele Lignani, Kristian Aquilina, Simon N. Waddington · 2025 · Pharmacological Reviews
100. Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks
     Paris Mazzachi, Ella McDonald, Zarina Greenberg, Alejandra Noreña Puerta, Jenne Tran, Manam Inushi De Silva, Cade Christensen, Robert Adams, Sebastian Loskarn, Helen Beard et al. · 2026 · Nature Communications